NEW ANTIPLATELET DRUGS (PART 1)
Antiplatelet agents are a necessary component of modern atherosclerosis therapy. The difficulties of antiplatelet treatment lie in the balance between the necessary therapeutic effect of the drug and the risk of excessive action leading to the bleeding. Possibility to control pharmacodynamics effect...
Saved in:
Main Author: | A. B. Sumarokov (Author) |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NEW ANTIPLATELET DRUGS (PART 1)
by: A. B. Sumarokov
Published: (2016) -
NEW ANTIPLATELET DRUGS. PART 2
by: A. B. Sumarokov
Published: (2016) -
INDIVIDUAL APPROACH TO PATIENTS WITH INDICATION FOR ANTIPLATELET THERAPY. WHAT TO RELY ON IN CHOOSING THE THERAPY?
by: N. V. LOMAKIN, et al.
Published: (2017) -
DENTAL CONSIDERATIONS IN PATIENTS TAKING NEW ANTIPLATELET AND ANTICOAGULANT DRUGS
by: Atanaska S. Dinkova, et al.
Published: (2020) -
Anti-glycation, antiplatelet and antioxidant effects of different pomegranate parts
by: Zahra Amri, et al.
Published: (2022)